04:58 PM EST, 03/07/2024 (MT Newswires) -- Down 17%, BioVaxys Technology Corp. ( BVAXF ) announced Thursday it is providing this bi-weekly update on the status of the management cease trade order granted on Feb. 29, 2024, by its principal regulator, the Ontario Securities Commission, following the company's announcement that it was unable to file its audited annual financial statements for the year ended Oct. 31, 2023, its management's discussion and analysis of financial statements for the year ending Oct. 31, 2023, its annual information form for the year ending Oct. 31, 2023 and related filings.

Under National Instrument 51-102, the Required Filings were required to be made not later than Feb. 28, 2024. The company still expects to file the Required Filings by March 30, 2024.

The company states that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Filings is continuing, each of which will be issued in the form of a press release.

Price: 0.07, Change: -0.0150, Percent Change: -17.6471